Global Niraparib Market Surges with Innovations in Oncology and Expanding Therapeutic Use The Niraparib Market is experiencing accelerated growth, driven by its increasing adoption in cancer therapeutics, particularly in the treatment of ovarian and other gynecological cancers. As a potent oral poly (ADP-ribose) polymerase (PARP) inhibitor, Niraparib is revolutionizing targeted therapy approaches, offering improved outcomes and prolonged progression-free survival for cancer patients...
0 Shares
198 Views
0 Reviews
Dutch